[PDF][PDF] The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical …
Introduction: Human papillomavirus (HPV) testing has become an essential part of current
clinical practice in the management of cervical cancer and precancerous lesions. We …
clinical practice in the management of cervical cancer and precancerous lesions. We …
[HTML][HTML] Suppl 1: Human Papillomavirus (HPV) Genoty**: Automation and Application in Routine Laboratory Testing
M Torres, L Fraile, JM Echevarria… - The Open Virology …, 2012 - ncbi.nlm.nih.gov
A large number of assays designed for genoty** human papillomaviruses (HPV) have
been developed in the last years. They perform within a wide range of analytical sensitivity …
been developed in the last years. They perform within a wide range of analytical sensitivity …
Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 Assays to Direct Sequencing and Genoty** …
Y Park, E Lee, J Choi, S Jeong… - Journal of clinical …, 2012 - Am Soc Microbiol
Infection with high-risk (HR) human papillomavirus (HPV) genotypes is an important risk
factor for cervical cancers. We evaluated the clinical performances of two new real-time PCR …
factor for cervical cancers. We evaluated the clinical performances of two new real-time PCR …
[HTML][HTML] Prevalence of human papilloma virus among women with breast cancer since 2005-2009 in Isfahan
Background: Human papilloma virus (HPV) DNA has been detected in breast carcinoma by
different laboratorial techniques, suggesting that the virus could play a role in the …
different laboratorial techniques, suggesting that the virus could play a role in the …
Prevalence of human papillomavirus and its genotype among 1336 invasive cervical cancer patients in Hunan province, central south China
L Wang, B Wu, J Li, L Chen - Journal of medical virology, 2015 - Wiley Online Library
Existing data on the genotype distribution of human papillomavirus (HPV) are limited in
Hunan province, central south China. To evaluate the prevalence of HPV infection and its …
Hunan province, central south China. To evaluate the prevalence of HPV infection and its …
Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting
Background Testing cervical smears for the presence of high-risk human papillomaviruses
(hrHPV) increases the sensitivity for detecting women with underlying high-grade cervical …
(hrHPV) increases the sensitivity for detecting women with underlying high-grade cervical …
Evaluation of a novel single-tube method for extended genoty** of human papillomavirus
R Bhatia, I Serrano, H Wennington… - Journal of Clinical …, 2018 - Am Soc Microbiol
The use of high-risk human papillomavirus (HPV) testing for surveillance and clinical
applications is increasing globally, and it is important that tests are evaluated to ensure they …
applications is increasing globally, and it is important that tests are evaluated to ensure they …
Improving laboratory efficiency by automation of preanalytic processing of ThinPrep specimens for real-time PCR high-risk HPV testing
D Barbieri, S Venturoli, S Costa… - Journal of Laboratory …, 2016 - journals.sagepub.com
Cervical specimens collected in liquid-based cytology (LBC) media are the most common
sample type used for high-risk human papillomavirus (HPV) testing. Since preanalytic steps …
sample type used for high-risk human papillomavirus (HPV) testing. Since preanalytic steps …
Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged≥ 30 years using residual LBC ThinPrep …
T Iftner, L Wang, A Iftner, B Holz… - BMC Infectious …, 2016 - Springer
Background High-risk human papillomavirus (HR HPV) testing is already part of cervical
cancer screening programs in a number of countries. New tests need to be validated not …
cancer screening programs in a number of countries. New tests need to be validated not …
Comparative evaluation of the Abbott HIV-1 RealTime™ assay with the standard Roche COBAS® Amplicor™ HIV-1 monitor® test, v1. 5 for determining HIV-1 RNA …
P Khopkar, V Mallav, S Chidrawar, S Kulkarni - Journal of virological …, 2013 - Elsevier
The implementation of cost effective HIV-1 viral load assays in resource-limited settings
have been an impediment for monitoring HIV-1 therapy. A study involving the comparative …
have been an impediment for monitoring HIV-1 therapy. A study involving the comparative …